ABVC BioPharma Inc (NASDAQ:ABVC) has a beta value of 0.33 and has seen 1.38 million shares traded in the recent trading session. The company, currently valued at $16.86M, closed the recent trade at $1.30 per share which meant it gained $0.24 on the day or 22.64% during that session. The ABVC stock price is -33.08% off its 52-week high price of $1.73 and 69.23% above the 52-week low of $0.40. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.16 million shares traded. The 3-month trading volume is 527.16K shares.
The consensus among analysts is that ABVC BioPharma Inc (ABVC) is Hold stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
ABVC BioPharma Inc (NASDAQ:ABVC) trade information
Sporting 22.64% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ABVC stock price touched $1.30 or saw a rise of 6.47%. Year-to-date, ABVC BioPharma Inc shares have moved 120.34%, while the 5-day performance has seen it change 88.95%. Over the past 30 days, the shares of ABVC BioPharma Inc (NASDAQ:ABVC) have changed 88.35%. Short interest in the company has seen 0.32 million shares shorted with days to cover at 0.24.
ABVC BioPharma Inc (ABVC) estimates and forecasts
The company’s shares have gained 89.15% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 12.78% over the past 5 years.
ABVC Dividends
ABVC BioPharma Inc is expected to release its next earnings report on 2023-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders
Insiders own 21.95% of the company shares, while shares held by institutions stand at 3.89% with a share float percentage of 4.98%. Investors are also buoyed by the number of investors in a company, with ABVC BioPharma Inc having a total of 15.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. As of Jan 31, 2025, the former fund manager holds about 0.39% shares in the company for having 51.24 shares of worth $67123.0 while later fund manager owns 46.95 shares of worth $61500.0 as of Dec 31, 2024, which makes it owner of about 0.36% of company’s outstanding stock.
